Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death
…, AI Webb, A Tripaydonis… - Proceedings of the …, 2014 - National Acad Sciences
Necroptosis is considered to be complementary to the classical caspase-dependent programmed
cell death pathway, apoptosis. The pseudokinase Mixed Lineage Kinase Domain-Like …
cell death pathway, apoptosis. The pseudokinase Mixed Lineage Kinase Domain-Like …
A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties
…, LN Varghese, K Chen, A Tripaydonis… - Biochemical …, 2014 - portlandpress.com
Protein kinase-like domains that lack conserved residues known to catalyse phosphoryl
transfer, termed pseudokinases, have emerged as important signalling domains across all …
transfer, termed pseudokinases, have emerged as important signalling domains across all …
Pediatric anthracycline‐induced cardiotoxicity: mechanisms, pharmacogenomics, and pluripotent stem‐cell modeling
A Tripaydonis, R Conyers… - Clinical Pharmacology & …, 2019 - Wiley Online Library
Anthracycline‐induced cardiotoxicity ( ACT ) is a severe adverse drug reaction for a subset of
children treated with anthracyclines as part of chemotherapy protocols. The identification of …
children treated with anthracyclines as part of chemotherapy protocols. The identification of …
[HTML][HTML] Evolutionary divergence of the necroptosis effector MLKL
…, SN Young, A Wardak, A Tripaydonis… - Cell Death & …, 2016 - nature.com
The pseudokinase, MLKL (mixed-lineage kinase domain-like), is the most terminal obligatory
component of the necroptosis cell death pathway known. Phosphorylation of the MLKL …
component of the necroptosis cell death pathway known. Phosphorylation of the MLKL …
Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop
The pseudokinase MLKL (mixed lineage kinase domain-like), has recently emerged as a
critical component of the necroptosis cell death pathway. Although it is clear that …
critical component of the necroptosis cell death pathway. Although it is clear that …
[HTML][HTML] A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction
…, H Anderton, JA Rickard, A Tripaydonis… - Nature …, 2020 - nature.com
MLKL is the essential effector of necroptosis, a form of programmed lytic cell death. We have
isolated a mouse strain with a single missense mutation, Mlkl D139V , that alters the two-…
isolated a mouse strain with a single missense mutation, Mlkl D139V , that alters the two-…
Chemotherapy‐related cardiotoxicity: are Australian practitioners missing the point?
…, B Costello, A La Gerche, A Tripaydonis… - Internal Medicine …, 2017 - Wiley Online Library
Background It has long been established that cardiotoxicity occurs as a result of exposure to
certain chemotherapeutics, particularly anthracyclines. Historically, clinicians equate …
certain chemotherapeutics, particularly anthracyclines. Historically, clinicians equate …
Missense mutations in the MLKL 'brace'region lead to lethal neonatal inflammation in mice and are present in high frequency in humans
…, K Rigbye, H Anderton, JA Rickard, A Tripaydonis… - bioRxiv, 2019 - biorxiv.org
We have isolated a mouse strain with a single missense mutation in the gene encoding MLKL,
the essential effector of necroptotic cell death. The resulting substitution lies within the two…
the essential effector of necroptotic cell death. The resulting substitution lies within the two…
[HTML][HTML] Building a Targeted Approach to Assess Risk of Anthracycline Induced Cardiomyopathy Amongst Paediatric Cancer Patients
A Tripaydonis, L Craig, LE Ludlow, M Cheung… - Blood, 2016 - Elsevier
Introduction Anthracyclines are chemotherapeutic agents used in the treatment of over 70%
of childhood and adolescent malignancies and their use has significantly improved cancer …
of childhood and adolescent malignancies and their use has significantly improved cancer …
[PDF][PDF] Adolescent survivor of childhood Acute Myeloid Leukaemia undertakes pregnancy with a severe anthracycline induced cardiomyopathy and risk taking …
A Tripaydonis, R Conyers - researchgate.net
A 16-year-old female survivor of childhood Acute Myeloid Leukaemia (AML) presented 12
weeks pregnant to her haematology oncology late effects appointment. Having failed to attend …
weeks pregnant to her haematology oncology late effects appointment. Having failed to attend …